SIM
VRTX icon

Seaview Investment Managers’s Vertex Pharmaceuticals VRTX Stock Holding History

Seaview Investment Managers’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-831
Closed -$234K – 111
2022
Q2 		$234K Sell
831
-28,199
-97% -$7.55M 0.11% 80
2022
Q1 		$7.58M Buy
+29,030
New +$6.89M 2.53% 17
2021
Q1 		– Sell
-14,608
Closed -$3.45M – 155
2020
Q4 		$3.45M Buy
14,608
+1,307
+10% +$300K 2.42% 24
2020
Q3 		$2.77M Buy
+13,301
New +$3.67M 2.55% 26

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Seaview Investment Managers's VRTX Position: Q3 2022 in Review

Seaview Investment Managers sold out of Vertex Pharmaceuticals (VRTX) in Q3 2022, closing a stake of 831 shares — an estimated $234K sold.

Seaview Investment Managers first reported a position in VRTX in Q3 2020 and held it in 4 quarters. The position peaked at $7.58M in Q1 2022. 1,124 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

  • Seaview Investment Managers reported no remaining Vertex Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Seaview Investment Managers sold 831 Vertex Pharmaceuticals shares in Q3 2022, an estimated $234K.
  • Seaview Investment Managers first reported a position in Vertex Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Seaview Investment Managers's Vertex Pharmaceuticals position peaked at $7.58M in Q1 2022.
  • 1,124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on Seaview Investment Managers's 13F filing for Q3 2022, filed 10 Nov 2022.